Malin eyes more investments and returning cash in 2022
Litigation-related costs came to €400,000 last year as founders sue for direct stake
Malin buys back €4.8m of its own shares
Purchase comes soon after life sciences group’s sale of Kymab stake
Malin on track to return €250m to shareholders – Davy
Cash return by Dublin-listed life sciences investment firm eclipses current market value
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Election 2024
Full general election coverage including analysis and results for all 43 constituencies
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices